Literature DB >> 2223103

Surfactant apoprotein A (SP-A) is synthesized in airway cells.

R L Auten1, R H Watkins, D L Shapiro, S Horowitz.   

Abstract

The pulmonary surfactant apoproteins A, B, and C (SP-A, SP-B, and SP-C, respectively) function in concert with surfactant phospholipids to reduce surface pressure in the alveolus. Surfactant apoproteins also regulate surfactant synthesis, secretion, adsorption, and recycling. SP-A and B have been localized by immunocytochemistry to alveolar epithelial (type II) cells, alveolar macrophages, and nonciliated bronchiolar epithelial (Clara) cells. In contrast, in situ hybridization to SP-A and B mRNA in human lung has shown SP-A and B transcripts in type II cells, but only SP-B message in Clara cells, implying that synthesis of SP-A occurs exclusively in type II cells. In this report, in situ hybridization to SP-A mRNA was performed on adult and developing rabbit lung and on human lung. SP-A transcripts were found in type II cells and bronchiolar epithelium of both species. The distribution of SP-A message-containing cells in the bronchiolar epithelium of rabbits and humans was similar to the distribution of Clara cells in these two species. These data indicate that SP-A is not only synthesized in type II cells but also in Clara cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2223103     DOI: 10.1165/ajrcmb/3.5.491

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  23 in total

1.  Glucocorticoid regulation of human pulmonary surfactant protein-B mRNA stability involves the 3'-untranslated region.

Authors:  Helen W Huang; Weizhen Bi; Gaye N Jenkins; Joseph L Alcorn
Journal:  Am J Respir Cell Mol Biol       Date:  2007-11-15       Impact factor: 6.914

2.  Surfactant protein A stimulates release of neutrophil chemotactic factors by alveolar type II pneumocytes.

Authors:  Mitchell J Kresch; Mitchell Block; Mohammed R Karim; Li Zhu; Naveed Hussain; Roger S Thrall; Ramadan I Sha'afi
Journal:  Lung       Date:  2010-05-16       Impact factor: 2.584

3.  Surfactant protein A is defective in abrogating inflammation in asthma.

Authors:  Ying Wang; Dennis R Voelker; Njira L Lugogo; Guirong Wang; Joanna Floros; Jennifer L Ingram; Hong Wei Chu; Tony D Church; Pitchaimani Kandasamy; Daniel Fertel; Jo Rae Wright; Monica Kraft
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-07-22       Impact factor: 5.464

4.  Surfactant abnormalities in infants with severe viral bronchiolitis.

Authors:  P A Dargaville; M South; P N McDougall
Journal:  Arch Dis Child       Date:  1996-08       Impact factor: 3.791

Review 5.  Surfactant replacement therapy.

Authors:  M J Kresch; W H Lin; R S Thrall
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

6.  Serum Clara cell protein levels in lung cancer patients: an assessment of preoperative values and postoperative changes.

Authors:  H Nomori; H Horio; R Kobayashi; S Morinaga
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

Review 7.  Surfactant protein-A: new insights into an old protein--II.

Authors:  A R Kumar; J M Snyder
Journal:  Indian J Pediatr       Date:  1998 Nov-Dec       Impact factor: 1.967

8.  Expression of cysteine dioxygenase (EC 1.13.11.20) and sulfite oxidase in the human lung: a potential role for sulfate production in the protection from airborne xenobiotica.

Authors:  J Millard; R B Parsons; R H Waring; A C Williams; D B Ramsden
Journal:  Mol Pathol       Date:  2003-10

9.  Protein 1 and Clara cell 10-kDa protein distribution in normal and neoplastic tissues with emphasis on the respiratory system.

Authors:  H Nomori; S Morinaga; R Kobayashi; C Torikata
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  Surfactant Protein-A Protects against IL-13-Induced Inflammation in Asthma.

Authors:  Dave Francisco; Ying Wang; Michelle Conway; Audriana N Hurbon; Alane B C Dy; Kenneth J Addison; Hong W Chu; Dennis R Voelker; Julie G Ledford; Monica Kraft
Journal:  J Immunol       Date:  2020-04-03       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.